title: Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
authors.forename: S
authors.initials: S
authors.lastname: Amadori
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: A
authors.initials: A
authors.lastname: Ceci
authors.forename: A
authors.initials: A
authors.lastname: Comelli
authors.forename: E
authors.initials: E
authors.lastname: Madon
authors.forename: G
authors.initials: G
authors.lastname: Masera
authors.forename: L
authors.initials: L
authors.lastname: Nespoli
authors.forename: G
authors.initials: G
authors.lastname: Paolucci
authors.forename: L
authors.initials: L
authors.lastname: Zanesco
authors.forename: D
authors.initials: D
authors.lastname: Defazio
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D007558:Italy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin